KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review-Reference-Cited by-同舟云学术

KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review

Published:2016-02-29 Issue:4 Volume:33 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Zhou Lei,Baba Yoshifumi,Kitano Yuki,Miyake Keisuke,Zhang Xiaobo,Yamamura Kensuke,Kosumi Keisuke,Kaida Takayoshi,Arima Kota,Taki Katsunobu,Higashi Takaaki,Imai Katsunori,Hashimoto Daisuke,Yamashita Yoichi,Chikamoto Akira,Beppu Toru,Tan Xiaodong,Baba Hideo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-016-0745-9.pdf

Reference41 articles.

1. Yatsuoka T, Sunamura M, Furukawa T, et al. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol. 2000;95(8):2080–5.

2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

3. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(22):2140–1.

4. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer. 2007;110(4):738–44.

5. Ulivi P, Arienti C, Amadori D, et al. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines. J Cell Physiol. 2009;220(1):214–21.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of a High‐Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor;Clinical Pharmacology in Drug Development;2024-07-17

2. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma;Journal of Clinical Medicine;2024-04-04

3. Targeting KRAS in PDAC: A New Way to Cure It?;Cancers;2022-10-11

4. Homologous recombination repair gene mutations in Malaysian prostate cancer patients;Cellular and Molecular Biology;2022-08-31

5. Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner;Anticancer Research;2022-07-26